Volume 15, Number 12—December 2009
Molecular Model of Prion Transmission to Humans
|PRNP amino acid sequence||Bovine||Human||Ovine||Ovine|
|PRNP polymorphism||140MM||129MM||ARQ/ARQ (132MM)||ARQ/ARQ (132MM)|
|PrP amino acid sequence||Human||Human||Human||Human|
|PRNP-129 polymorphism||MM, MV, and VV||MM, MV, and VV||MM, MV, and VV||MM, MV, and VV|
|Background genotype||129 Ola prnp−/−||129 Ola prnp−/−||129 Ola prnp−/−||129 Ola prnp−/−|
*PMCA, protein misfolding cyclic amplification; vCJD, variant Creutzfeldt-Jakob disease; BSE, bovine spongiform encephalopathy; PrPres, protease-resistant prion protein; PrPd, disease-associated prion protein; MM, methionine homozygous; MV, methionine/valine heterozygous; VV, valine homozygous.
†Bovine brain tissue was sampled from brain tissue taken from a Friesian cow with terminal BSE (11).
‡Human brain tissue (frontal cortex) was sampled from a frozen half brain that had been collected at autopsy with the appropriate consent for tissue retention and research use from a patient methionine homozygous at PRNP codon 129, who received a final diagnosis of definite vCJD by established criteria. Ethical approval for its use in this study was covered by LREC 2000/4/157 (J.W.I.).
§Both the ovine scrapie (12) and ovine BSE (13) brain tissue (hind brain) were sampled from clinically sick sheep. The distinctive disease phenotypes were confirmed by histopathologic, immunohistochemical, and Western blot characteristics.
¶Frozen half brains from inbred transgenic mouse lines expressing human PrP of the 3 major PRNP codon-129 genotypes (MM, MV, VV) were used to prepare substrate homogenates. These mice had identical genetic backgrounds, were produced to express human PrP by direct replacement of the murine PrP gene, and all expressed equivalent amounts of human PrP regardless of the PRNP-129 genotype (14). The transgenic mice were bred under license to the UK Home Office in accordance with the UK Animals (Scientific Procedures) Act of 1986, and the use of brain tissue from these mice was reviewed and approved by the local Ethics Review Committee.
- Bruce ME. TSE strain variation. Br Med Bull. 2003;66:99–108.
- Prusiner SB. Prions. Proc Natl Acad Sci U S A. 1998;95:13363–83.
- Collinge J, Clark AR. A general model of prion strains and their pathogenicity. Science. 2007;318:930–6.
- Will RG, Ironside JW, Zeidler M, Cousens SN, Estibeiro K, Alperovitch A, Lancet. 1996;347:921–5.
- Collinge J, Sidle KC, Meads J, Ironside J, Hill AF. Molecular analysis of prion strain variation and the aetiology of ‘new variant’ CJD. Nature. 1996;383:685–90.
- Head MW, Bunn TJ, Bishop MT, McLoughlin V, Lowrie S, McKimmie J, Prion protein heterogeneity in sporadic but not variant Creutzfeldt-Jakob disease: UK cases 1991–2002. Ann Neurol. 2004;55:851–9.
- Eloit M, Adjou K, Coulpier M, Fontaine JJ, Hamel R, Lilin T, BSE agent signatures in a goat. Vet Rec. 2005;156:523–4.
- Supattapone S. Prion protein conversion in vitro. J Mol Med. 2004;82:348–56.
- Saborio GP, Permanne B, Soto C. Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature. 2001;411:810–3.
- Jones M, Peden AH, Prowse CV, Groner A, Manson JC, Turner ML, In vitro amplification and detection of variant Creutzfeldt-Jakob disease PrPSc. J Pathol. 2007;213:21–6.
- Yull HM, Ritchie DL, Langeveld JP, van Zijderveld FG, Bruce ME, Ironside JW, Detection of type 1 prion protein in variant Creutzfeldt-Jakob disease. Am J Pathol. 2006;168:151–7.
- Jeffrey M, Martin S, Thomson JR, Dingwall WS, Begara-McGorum I, Gonzalez L. Onset and distribution of tissue prp accumulation in scrapie-affected Suffolk sheep as demonstrated by sequential necropsies and tonsillar biopsies. J Comp Pathol. 2001;125:48–57.
- Gonzalez L, Chianini F, Martin S, Siso S, Gibbard L, Reid HW, Comparative titration of experiment ovine BSE infectivity in sheep and mice. J Gen Virol. 2007;88:714–7.
- Bishop MT, Hart P, Aitchison L, Baybutt HN, Plinston C, Thomson V, Predicting susceptibility and incubation time of human-to-human transmission of vCJD. Lancet Neurol. 2006;5:393–8.
- Manson JC, Cancellotti E, Hart P, Bishop MT, Barron RM. The transmissible spongiform encephalopathies: emerging and declining epidemics. Biochem Soc Trans. 2006;34:1155–8.